Stock Information
AbbVie Inc (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $388,784.14 mil
Piotroski score: 7
PE Ratio: 162.9872
EPS (TTM): 1.3479
Revenue (TTM): $33.66 M
Dividend Yield: 3.1560705%
ROE: 95.59%
Latest News
-
How Recent Price Target Rethinks Are Rewriting The Story For AbbVie (ABBV)
Mon, Jan 26, 2026 4:21 PM
-
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Mon, Jan 26, 2026 2:00 PM
-
MSD ends takeover talks with Revolution Medicines
Mon, Jan 26, 2026 12:19 PM
-
The Best Dividend Stocks to Buy and Hold Forever
Mon, Jan 26, 2026 9:05 AM
-
Best Dividend Kings: January 2026
Sun, Jan 25, 2026 10:11 PM
-
Merck No Longer in Talks to Buy Revolution Medicines
Sun, Jan 25, 2026 7:30 PM
-
3 Stocks Including Datadog That May Be Priced Below Their Estimated Value
Fri, Jan 23, 2026 11:38 AM
-
Genmab: Darzalex Growth Fuels Rally, Upside Is Tight
Fri, Jan 23, 2026 9:50 AM
-
AbbVie Dodged a Patent Disaster, and Shares Gained 460%. Merck and Bristol Myers Are Next.
Fri, Jan 23, 2026 6:30 AM
-
ABBV vs. MRK: An Oncology-Immunology Showdown for Investors
Thu, Jan 22, 2026 5:03 PM
Key Financials
Financial data not available